Avneesh Kumar Gautam, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Complement C3b | 2 | 2022 | 98 | 0.720 |
Why?
|
Complement Factor I | 1 | 2015 | 14 | 0.520 |
Why?
|
Herpesvirus 8, Human | 1 | 2015 | 256 | 0.440 |
Why?
|
Viral Proteins | 2 | 2017 | 1803 | 0.390 |
Why?
|
Multiprotein Complexes | 1 | 2015 | 1112 | 0.320 |
Why?
|
Immune Evasion | 2 | 2021 | 377 | 0.290 |
Why?
|
Models, Molecular | 3 | 2021 | 5443 | 0.290 |
Why?
|
Complement Factor H | 1 | 2022 | 110 | 0.200 |
Why?
|
Membrane Fusion | 1 | 2021 | 265 | 0.170 |
Why?
|
Complement C3 | 1 | 2020 | 434 | 0.150 |
Why?
|
Complement Pathway, Classical | 1 | 2017 | 91 | 0.150 |
Why?
|
Antibodies, Viral | 4 | 2022 | 3212 | 0.140 |
Why?
|
Complement Pathway, Alternative | 1 | 2017 | 113 | 0.140 |
Why?
|
Viral Tropism | 1 | 2017 | 102 | 0.140 |
Why?
|
Complement System Proteins | 1 | 2019 | 739 | 0.130 |
Why?
|
Viral Matrix Proteins | 1 | 2017 | 193 | 0.130 |
Why?
|
Antibody Formation | 1 | 2020 | 1393 | 0.130 |
Why?
|
Eye | 1 | 2020 | 715 | 0.130 |
Why?
|
Immunoglobulins | 1 | 2019 | 856 | 0.130 |
Why?
|
Complement Activation | 1 | 2017 | 448 | 0.130 |
Why?
|
Protein Structure, Quaternary | 1 | 2015 | 429 | 0.120 |
Why?
|
Lymphocyte Activation | 2 | 2020 | 5495 | 0.100 |
Why?
|
Retina | 2 | 2020 | 2663 | 0.100 |
Why?
|
Antibody Affinity | 2 | 2021 | 252 | 0.080 |
Why?
|
Immunoglobulin G | 1 | 2020 | 4572 | 0.080 |
Why?
|
Protein Structure, Tertiary | 1 | 2015 | 3790 | 0.080 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 4419 | 0.070 |
Why?
|
Antigens, Viral | 2 | 2021 | 992 | 0.070 |
Why?
|
B-Lymphocytes | 1 | 2019 | 4781 | 0.060 |
Why?
|
Mutation | 4 | 2022 | 30243 | 0.060 |
Why?
|
Protein Conformation | 2 | 2021 | 3973 | 0.050 |
Why?
|
Neutralization Tests | 1 | 2022 | 740 | 0.040 |
Why?
|
Protein Binding | 2 | 2022 | 9376 | 0.040 |
Why?
|
Antibody Diversity | 1 | 2019 | 72 | 0.040 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2021 | 452 | 0.040 |
Why?
|
Somatic Hypermutation, Immunoglobulin | 1 | 2019 | 103 | 0.040 |
Why?
|
Complement C4b-Binding Protein | 1 | 2017 | 1 | 0.040 |
Why?
|
Intravitreal Injections | 1 | 2020 | 401 | 0.040 |
Why?
|
Macaca fascicularis | 1 | 2020 | 903 | 0.040 |
Why?
|
Protein Subunits | 1 | 2021 | 943 | 0.040 |
Why?
|
Cryoelectron Microscopy | 1 | 2021 | 652 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2021 | 1744 | 0.030 |
Why?
|
Protein Multimerization | 1 | 2021 | 980 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2020 | 2298 | 0.030 |
Why?
|
Vaccinia virus | 1 | 2017 | 330 | 0.030 |
Why?
|
Epitopes | 1 | 2021 | 2526 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2020 | 1339 | 0.030 |
Why?
|
Antibodies | 1 | 2022 | 2425 | 0.030 |
Why?
|
Autoantigens | 1 | 2019 | 894 | 0.030 |
Why?
|
Biocompatible Materials | 1 | 2022 | 1703 | 0.030 |
Why?
|
Animals | 6 | 2023 | 169418 | 0.030 |
Why?
|
Fibrinogen | 1 | 2017 | 892 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2017 | 2184 | 0.030 |
Why?
|
Species Specificity | 1 | 2017 | 2422 | 0.030 |
Why?
|
Humans | 11 | 2022 | 768451 | 0.030 |
Why?
|
Antibodies, Neutralizing | 1 | 2022 | 2008 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2021 | 4294 | 0.020 |
Why?
|
Cattle | 1 | 2017 | 3830 | 0.020 |
Why?
|
Autoimmunity | 1 | 2019 | 1361 | 0.020 |
Why?
|
Peptides | 1 | 2022 | 4368 | 0.020 |
Why?
|
Cell Lineage | 1 | 2019 | 2575 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10784 | 0.020 |
Why?
|
Cell Line | 1 | 2021 | 15609 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2017 | 13452 | 0.020 |
Why?
|
Mice | 2 | 2022 | 82045 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 40271 | 0.010 |
Why?
|
Aged | 1 | 2020 | 171520 | 0.000 |
Why?
|